Latest filing published 02 Feb 2021 for Panacea Life Sciences Holdings, INC., €168k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Andrew L. Johnson: trading record in brief
This profile gathers the share dealings of Andrew L. Johnson in Panacea Life Sciences Holdings, Inc. Over a trading history stretching from 18 December 2019 to 22 January 2021, the count stands at 3 filings.
On the market, this insider has only ever bought: 1 purchase, €22k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants.
Most recently, on 2 February 2021, the filings show a share grant worth €168k in Panacea Life Sciences Holdings, Inc. The last purchase on record was published on 19 December 2019, which is 2,517 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Andrew L. Johnson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,186,240 shares@ US$0.02588.2% of flowCommon StockSEC:0001415889-21-000478:0
- 250,000 shares0Common StockSEC:0001415889-20-000288:0
- 62,500 shares@ US$0.40100.0% of flowCommon StockSEC:0001415889-19-001542:0Canonical exit: 17 Mar 2020 (T+90)
3 of 3 declarations